Medicine information TOLVAPTAN STADA 30mg tablets

Product code:
W72259001
Quantity:
7
Indicated for:
hyponatremia; autosomal dominant polycystic kidney disease
Route of administration:
oral
Substance:
tolvaptan (diuretic)
ATC
C03XA01 — Cardiovascular system | Other diuretics | Vasopressin antagonists
Tolvaptan is a selective vasopressin V2 receptor antagonist used in the treatment of hyponatremia associated with the syndrome of inappropriate antidiuretic hormone secretion (SIADH) and in the management of autosomal dominant polycystic kidney disease (ADPKD). It works by blocking the effects of vasopressin in the renal collecting ducts, increasing free water excretion and correcting hyponatremia.

Tolvaptan is administered orally, usually once daily, with the dose adjusted based on the patient's response and serum sodium levels. In ADPKD, the treatment aims to slow disease progression and reduce the growth of renal cysts.

Common side effects include thirst, polyuria, dry mouth, and fatigue. In rare cases, severe adverse reactions such as liver function impairment may occur, necessitating regular monitoring of liver enzymes.

Tolvaptan is an innovative therapeutic option for patients with hyponatremia and ADPKD, contributing to improved quality of life and prevention of complications associated with these conditions.

General data about TOLVAPTAN STADA 30mg

Substance:
tolvaptan
Date of latest medicines list:
01-11-2026
Product code:
W72259001
Strength:
30mg
Pharmaceutical form:
tablets
Quantity:
7
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
CORIPHARMA EHF. - ISLANDA
Holder:
STADA ARZNEIMITTEL AG - GERMANIA
Number:
16922/2026/01
Shelf life:
3 years

Strengths available for tolvaptan

  • 15mg
  • 15mg+45mg
  • 30mg
  • 30mg+60mg
  • 30mg+90mg

Warnings:

Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Electrolyte disturbances

This medicine may change blood electrolyte levels.